🔎 Trials Near Me

Hjem › Lupus › Arizona

Lupus kliniske forsøg i Arizona

7 studier for Lupus søger deltagere på steder i Arizona.

Byer i Arizona

Officiel studietekst (engelsk)

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

  • Sl0044 50058, Avondale
  • Sl0044 50550, Chandler
  • Sl0044 50713, Gilbert
  • og 3 flere
RekruttererFase 3
Alder 16 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06617325

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

  • Research Site, Phoenix
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT05835310

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

  • Research Site, Phoenix
  • Research Site, Tucson
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 25. sep. 2026 · NCT07430306

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Mayo Clinic, Phoenix
RekruttererFase 1
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

  • HonorHealth Research and Innovation Institute, Scottsdale
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 21. aug. 2026 · NCT06570798

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

  • AARA Clinical Research, Avondale
  • AARA Clinical Research, Tucson
RekruttererFase 1
Alder 18 til 70 · Alle køn · Opdateret 5. jun. 2026 · NCT06613360

Lupus Landmark Study: A Prospective Registry and Biorepository

  • University of Arizona, Tucson
RekruttererObservationsstudie
Alder 18 til 110 · Alle køn · Opdateret 15. apr. 2026 · NCT05934149

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.